These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 38965136

  • 1. Immune checkpoint inhibitor-associated new-onset hypophysitis: a retrospective analysis using the FAERS.
    Lu D, Yao J, Yuan G, Gao Y, Zhang J, Guo X.
    Endocrine; 2024 Oct; 86(1):342-348. PubMed ID: 38965136
    [Abstract] [Full Text] [Related]

  • 2. Immune checkpoint inhibitor-associated new-onset primary adrenal insufficiency: a retrospective analysis using the FAERS.
    Lu D, Yao J, Yuan G, Gao Y, Zhang J, Guo X.
    J Endocrinol Invest; 2022 Nov; 45(11):2131-2137. PubMed ID: 35870109
    [Abstract] [Full Text] [Related]

  • 3. Immune Checkpoint Inhibitor-related New-onset Thyroid Dysfunction: A Retrospective Analysis Using the US FDA Adverse Event Reporting System.
    Lu D, Yao J, Yuan G, Gao Y, Zhang J, Guo X.
    Oncologist; 2022 Mar 04; 27(2):e126-e132. PubMed ID: 35641200
    [Abstract] [Full Text] [Related]

  • 4. Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival.
    Johnson J, Goldner W, Abdallah D, Qiu F, Ganti AK, Kotwal A.
    J Natl Compr Canc Netw; 2023 Feb 24; 21(3):281-287. PubMed ID: 36828029
    [Abstract] [Full Text] [Related]

  • 5. Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system.
    Zhai Y, Ye X, Hu F, Xu J, Guo X, Zhuang Y, He J.
    J Immunother Cancer; 2019 Nov 06; 7(1):286. PubMed ID: 31694698
    [Abstract] [Full Text] [Related]

  • 6. Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database.
    Mikami T, Liaw B, Asada M, Niimura T, Zamami Y, Green-LaRoche D, Pai L, Levy M, Jeyapalan S.
    J Neurooncol; 2021 Mar 06; 152(1):135-144. PubMed ID: 33423151
    [Abstract] [Full Text] [Related]

  • 7. Immune checkpoint inhibitor-associated pituitary adverse events: an observational, retrospective, disproportionality study.
    Bai X, Chen X, Wu X, Huang Y, Zhuang Y, Chen Y, Feng C, Lin X.
    J Endocrinol Invest; 2020 Oct 06; 43(10):1473-1483. PubMed ID: 32239475
    [Abstract] [Full Text] [Related]

  • 8. Differences in checkpoint-inhibitor-induced hypophysitis: mono- versus combination therapy induced hypophysitis.
    van der Leij S, Suijkerbuijk KPM, van den Broek MFM, Valk GD, Dankbaar JW, van Santen HM.
    Front Endocrinol (Lausanne); 2024 Oct 06; 15():1400841. PubMed ID: 39135626
    [Abstract] [Full Text] [Related]

  • 9. Mechanistic insights into immune checkpoint inhibitor-related hypophysitis: a form of paraneoplastic syndrome.
    Kanie K, Iguchi G, Bando H, Urai S, Shichi H, Fujita Y, Matsumoto R, Suda K, Yamamoto M, Fukuoka H, Ogawa W, Takahashi Y.
    Cancer Immunol Immunother; 2021 Dec 06; 70(12):3669-3677. PubMed ID: 33977343
    [Abstract] [Full Text] [Related]

  • 10. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
    Ferrara R, Imbimbo M, Malouf R, Paget-Bailly S, Calais F, Marchal C, Westeel V.
    Cochrane Database Syst Rev; 2020 Dec 14; 12(12):CD013257. PubMed ID: 33316104
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
    Muir CA, Clifton-Bligh RJ, Long GV, Scolyer RA, Lo SN, Carlino MS, Tsang VHM, Menzies AM.
    J Clin Endocrinol Metab; 2021 Aug 18; 106(9):e3704-e3713. PubMed ID: 33878162
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.